See rituximab in All languages combined, or Wiktionary
{
"etymology_templates": [
{
"args": {
"1": "en",
"2": "",
"3": "-tu-",
"4": "-ximab",
"t2": "tumor",
"t3": "chimeric monoclonal antibody"
},
"expansion": "[Term?] + -tu- (“tumor”) + -ximab (“chimeric monoclonal antibody”)",
"name": "af"
}
],
"etymology_text": "From [Term?] + -tu- (“tumor”) + -ximab (“chimeric monoclonal antibody”).",
"forms": [
{
"form": "rituximabs",
"tags": [
"plural"
]
}
],
"head_templates": [
{
"args": {
"1": "-",
"2": "s"
},
"expansion": "rituximab (usually uncountable, plural rituximabs)",
"name": "en-noun"
}
],
"lang": "English",
"lang_code": "en",
"pos": "noun",
"senses": [
{
"categories": [
{
"kind": "other",
"name": "English entries with incorrect language header",
"parents": [
"Entries with incorrect language header",
"Entry maintenance"
],
"source": "w"
},
{
"kind": "other",
"name": "English terms interfixed with -tu-",
"parents": [],
"source": "w"
},
{
"kind": "other",
"name": "English terms suffixed with -ximab",
"parents": [],
"source": "w"
},
{
"kind": "other",
"name": "Pages with 2 entries",
"parents": [],
"source": "w"
},
{
"kind": "other",
"name": "Pages with entries",
"parents": [],
"source": "w"
},
{
"kind": "topical",
"langcode": "en",
"name": "Pharmaceutical drugs",
"orig": "en:Pharmaceutical drugs",
"parents": [
"Drugs",
"Matter",
"Pharmacology",
"Chemistry",
"Nature",
"Biochemistry",
"Medicine",
"Sciences",
"All topics",
"Biology",
"Healthcare",
"Fundamental",
"Health",
"Body"
],
"source": "w"
}
],
"glosses": [
"A chimeric monoclonal antibody (trademark Rituxan) administered by intravenous injection especially to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia by binding to the protein CD20 found on the surface of B cells and causing their lysis."
],
"id": "en-rituximab-en-noun-WNCEwzpt",
"links": [
[
"pharmacology",
"pharmacology"
],
[
"chimeric",
"chimeric"
],
[
"monoclonal antibody",
"monoclonal antibody"
],
[
"intravenous",
"intravenous"
],
[
"injection",
"injection"
],
[
"protein",
"protein"
],
[
"CD20",
"CD20"
],
[
"B cell",
"B cell"
],
[
"lysis",
"lysis"
]
],
"raw_glosses": [
"(pharmacology) A chimeric monoclonal antibody (trademark Rituxan) administered by intravenous injection especially to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia by binding to the protein CD20 found on the surface of B cells and causing their lysis."
],
"synonyms": [
{
"word": "IDEC-C2B8"
}
],
"tags": [
"uncountable",
"usually"
],
"topics": [
"medicine",
"pharmacology",
"sciences"
],
"wikipedia": [
"rituximab"
]
}
],
"sounds": [
{
"ipa": "/ɹɪˈtʌk.sɪˌmæb/",
"tags": [
"General-American"
]
}
],
"word": "rituximab"
}
{
"etymology_templates": [
{
"args": {
"1": "en",
"2": "",
"3": "-tu-",
"4": "-ximab",
"t2": "tumor",
"t3": "chimeric monoclonal antibody"
},
"expansion": "[Term?] + -tu- (“tumor”) + -ximab (“chimeric monoclonal antibody”)",
"name": "af"
}
],
"etymology_text": "From [Term?] + -tu- (“tumor”) + -ximab (“chimeric monoclonal antibody”).",
"forms": [
{
"form": "rituximabs",
"tags": [
"plural"
]
}
],
"head_templates": [
{
"args": {
"1": "-",
"2": "s"
},
"expansion": "rituximab (usually uncountable, plural rituximabs)",
"name": "en-noun"
}
],
"lang": "English",
"lang_code": "en",
"pos": "noun",
"senses": [
{
"categories": [
"English countable nouns",
"English entries with incorrect language header",
"English lemmas",
"English nouns",
"English term requests",
"English terms interfixed with -tu-",
"English terms suffixed with -ximab",
"English uncountable nouns",
"Pages with 2 entries",
"Pages with entries",
"en:Pharmaceutical drugs"
],
"glosses": [
"A chimeric monoclonal antibody (trademark Rituxan) administered by intravenous injection especially to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia by binding to the protein CD20 found on the surface of B cells and causing their lysis."
],
"links": [
[
"pharmacology",
"pharmacology"
],
[
"chimeric",
"chimeric"
],
[
"monoclonal antibody",
"monoclonal antibody"
],
[
"intravenous",
"intravenous"
],
[
"injection",
"injection"
],
[
"protein",
"protein"
],
[
"CD20",
"CD20"
],
[
"B cell",
"B cell"
],
[
"lysis",
"lysis"
]
],
"raw_glosses": [
"(pharmacology) A chimeric monoclonal antibody (trademark Rituxan) administered by intravenous injection especially to treat non-Hodgkin lymphoma and chronic lymphocytic leukemia by binding to the protein CD20 found on the surface of B cells and causing their lysis."
],
"tags": [
"uncountable",
"usually"
],
"topics": [
"medicine",
"pharmacology",
"sciences"
],
"wikipedia": [
"rituximab"
]
}
],
"sounds": [
{
"ipa": "/ɹɪˈtʌk.sɪˌmæb/",
"tags": [
"General-American"
]
}
],
"synonyms": [
{
"word": "IDEC-C2B8"
}
],
"word": "rituximab"
}
Download raw JSONL data for rituximab meaning in English (2.0kB)
This page is a part of the kaikki.org machine-readable English dictionary. This dictionary is based on structured data extracted on 2024-12-15 from the enwiktionary dump dated 2024-12-04 using wiktextract (8a39820 and 4401a4c). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.
If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.